Glenmark Pharmaceuticals Ltd

GLENMARK

Company Profile

  • Business description

    Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe and the Rest of the world.

  • Contact

    B. D. Sawant Marg
    Glenmark House
    Chakala, Off Western Express Highway
    Andheri (East)
    MumbaiMH400099
    IND

    T: +91 2240189999

    E: [email protected]

    https://www.glenmarkpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    16,623

Stocks News & Analysis

stocks

The ‘other’ AI chip behemoth that might just be getting started

The magnitude of growth at Broadcom continues to astound us.
stocks

Why ANZ changes aren’t just about cutting costs

The banking major needs to prevent key product offerings from falling further behind the competition.
stocks

Strong finish to the year for overvalued ASX share

A great fiscal 2025 but investors are ahead of themselves.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,095.2028.800.32%
CAC 407,761.3211.930.15%
DAX 4023,632.9585.50-0.36%
Dow JONES (US)45,490.92220.42-0.48%
FTSE 1009,225.3917.14-0.19%
HKSE26,200.26262.131.01%
NASDAQ21,886.066.570.03%
Nikkei 22543,837.67378.380.87%
NZX 50 Index13,276.2422.510.17%
S&P 5006,532.0419.430.30%
S&P/ASX 2008,830.4040.000.46%
SSE Composite Index3,812.224.930.13%

Market Movers